In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

G&W Laboratories Inc.

www.gwlabs.com

Latest From G&W Laboratories Inc.

Generic Industry Consolidating But Still Mysterious

Nearly 2,000 ANDAs remain unclaimed as US FDA begins fee calculations for GDUFA II.

Generic Drugs FDA

Generic Industry Consolidating But Still Mysterious

Nearly 2,000 ANDAs remain unclaimed as US FDA begins fee calculations for GDUFA II.

Generic Drugs FDA

Deals Shaping The Medical Industry, March 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in February 2016.

BioPharmaceutical Medical Device

FTC Says Three Is Not Enough: Lupin Must Divest To Acquire Gavis, Novel

Merger would leave three companies selling antibiotic doxycycline, but Gavis must still transfer its product to G&W Laboratories as a condition of $850m acquisition.

BioPharmaceutical India
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • G&W Laboratories Inc.
  • Senior Management
  • Aaron Greenblatt, PharmD, CEO
    Peter Milligan, CFO
    Eric M Mittleberg, PhD, VP, CSO
    Erika G Vogel-Baylor, VP, Sales & Mktg.
    Ronald Greenblatt, Chairman
    Kurt Orlofski, President
    Darren Alkins, VP, Bus Dev & Alliance Management
    James Coy, Chief Integration Officer
    Christian Cunningham, VP, Bus Dev Finance
    Robert Darienzo, COO
    Bradley Gambill, Chief Strategy Officer
    Kumar Kantheti, VP, Portfolio Management
    Hermant Kumar, CIO
  • Contact Info
  • G&W Laboratories Inc.
    Phone: (800) 922-1038
    111 Coolidge St.
    South Plainfield, NJ 07080-3895
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register